Chlorogenic Acid Improves Anti-Lipogenic Activity of Metformin by Positive Regulating of Ampk Signaling in Hepg2 Cells Publisher Pubmed



Namvarjah F¹ ; Shokriafra H² ; Moradisardareh H^{3, 4} ; Khorzoughi RB¹ ; Pasalar P¹ ; Panahi G¹ ; Meshkani R¹ Show Affiliations
Source: Cell Biochemistry and Biophysics Published:2022

Abstract

Metformin improves lipid profile, however, combination therapy is developing to increase its effectiveness and reduce the deleterious effects of metformin. Chlorogenic acid (CGA) has exhibited lipid-lowering effects. This study aimed to investigate the combined effect of metformin and CGA on lipid accumulation, as well as to elucidate the engaged mechanism in HepG2 cells. To find the non-lethal doses of metformin and CGA, MTT assay was performed. High Glucose (HG) at 33 mM was used to induce lipogenesis in HepG2 cells. Following treatment with different concentrations of metformin and CGA, total lipid content (Oil Red O-staining), triglyceride level, the genes expression of SREBP-1c and FAS, and phosphorylation of AMPK and ACC were measured. Both Metformin and CGA decreased HG-induced lipid accumulation individually, by decreasing total lipid content and triglyceride level. The lowest effective doses of metformin and CGA were 0.25 mM and 5 μM, respectively, which significantly reduced SREBP-1c and FAS genes expression. The combination of these concentrations reinforced these effects. The phosphorylation of AMPK and ACC were more increased by metformin in combination with CGA than both individually. Our findings suggest that CGA synergistically enhances metformin lipid reducing action via the regulating of involved factors in fatty acid synthesis. Therefore, co-administration of metformin with CGA may have further medical value in treating lipid metabolism disorders. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.